US 8748114
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
granted A61PA61P35/02
Quick answer
US patent 8748114 (ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/02